634 West Main Street
About Propeller Health
Propeller is the leading digital platform for respiratory health management. Through sensors, mobile apps and services, Propeller helps reduce the cost of care while delivering better quality of life for individuals with chronic respiratory disease.
Founder and CEO: David Van Sickle
Founder and CTO: Greg Tracy
COO: Chris Hogg
CMO: Michelle Snyder
16 articles with Propeller Health
Safeguard to realize $41.4 million in cash proceeds, representing an approximate 3x cash-on-cash return and 34% IRR
ResMed is now poised to provide a broader suite of solutions for COPD treatment
Safeguard Scientifics, Inc.. (NYSE:SFE) (Safeguard or the Company) today announced that its partner company, Propeller Health, signed a definitive agreement to be acquired by ResMed (NYSE:RMD) (ASX:RMD) for $225 million in cash.
ResMed to Acquire Propeller Health, a Leader in COPD and Asthma Connected Health Solutions, for $225 Million
Establishes ResMed as a leader in COPD patient management, across all stages of the disease
Digital Medicine Data Shows Asthma Assessment Guidelines Are Outdated, According to Propeller Health Study
MADISON, Wis., /PRNewswire/ -- New research from Propeller Health, a leading digital therapeutics company, suggests that clinical guidelines for assessing asthma control may need to be updated to reflect objective patient information obtained from digital medicines.
Strategic investment of an undisclosed amount from McKesson Ventures, adding to the $20M funding round announced last week.
Peer-Reviewed Study Demonstrates High Patient Satisfaction with Propeller Health's Digital Medicines for Asthma
A new peer-reviewed study published in the Journal of Medical Internet Research mHealth and uHealth demonstrated high levels of patient satisfaction with Propeller Health's digital medicines for asthma.
Propeller Health Raises $20 Million, Accelerating Development of Digital Medicines for Respiratory Health and Other Diseases
Financing led by Aptar Pharma, with participation from existing investors Safeguard Scientifics, Social Capital, Hikma, 3M Ventures and SR One
Propeller Health Publishes Results From a Large Public Health Study on Asthma; Successfully Reduces the Burden of Asthma in Louisville
Propeller Health and peer-reviewed healthcare journal, Health Affairs, published results from a cross-sector partnership in Louisville, KY, that successfully reduced the burden of asthma.
Propeller Health Presents Data On Asthma And COPD At The European Respiratory Society International Congress
Propeller Health Announces Expansion Of Digital Health Collaboration With GlaxoSmithKline To Improve Management Of Asthma And COPD
Propeller Health And MIR Announce License Agreement And Collaboration To Integrate Mobile And Clinic-Based Spirometers Into The Propeller Platform